Page last updated: 2024-10-31

moclobemide and Depressive Disorder, Treatment-Resistant

moclobemide has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lafrenière, S1
Blier, P1

Other Studies

1 other study available for moclobemide and Depressive Disorder, Treatment-Resistant

ArticleYear
Remission from severe treatment-resistant depression with moclobemide: A case report.
    L'Encephale, 2023, Volume: 49, Issue:6

    Topics: Causality; Depression; Depressive Disorder, Treatment-Resistant; Humans; Moclobemide; Monoamine Oxid

2023